192 related articles for article (PubMed ID: 27350276)
1. Lipid Nanocarrier-Mediated Drug Delivery System to Enhance the Oral Bioavailability of Rifabutin.
Nirbhavane P; Vemuri N; Kumar N; Khuller GK
AAPS PharmSciTech; 2017 Apr; 18(3):829-837. PubMed ID: 27350276
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel.
Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR
Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431
[TBL] [Abstract][Full Text] [Related]
3. Rifabutin-loaded solid lipid nanoparticles for inhaled antitubercular therapy: Physicochemical and in vitro studies.
Gaspar DP; Faria V; Gonçalves LM; Taboada P; Remuñán-López C; Almeida AJ
Int J Pharm; 2016 Jan; 497(1-2):199-209. PubMed ID: 26656946
[TBL] [Abstract][Full Text] [Related]
4. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
[TBL] [Abstract][Full Text] [Related]
5. Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats.
Thirupathi G; Swetha E; Narendar D
Drug Res (Stuttg); 2017 Mar; 67(3):163-169. PubMed ID: 27992936
[TBL] [Abstract][Full Text] [Related]
6. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
7. Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis.
Pinheiro M; Ribeiro R; Vieira A; Andrade F; Reis S
Drug Des Devel Ther; 2016; 10():2467-75. PubMed ID: 27536067
[TBL] [Abstract][Full Text] [Related]
8. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
[TBL] [Abstract][Full Text] [Related]
9. Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation.
Nooli M; Chella N; Kulhari H; Shastri NR; Sistla R
Drug Dev Ind Pharm; 2017 Apr; 43(4):611-617. PubMed ID: 28005442
[TBL] [Abstract][Full Text] [Related]
10. Preparation, optimization, characterization and in vivo pharmacokinetic study of asiatic acid tromethamine salt-loaded solid lipid nanoparticles.
Lingling G; Yuan Z; Weigen L
Drug Dev Ind Pharm; 2016 Aug; 42(8):1325-33. PubMed ID: 26821124
[TBL] [Abstract][Full Text] [Related]
11. Spray-dried Solid Lipid Nanoparticles for Enhancing Berberine Bioavailability
Nguyen VH; Le KNM; Nguyen MCN
Curr Pharm Des; 2023; 29(38):3050-3059. PubMed ID: 37961862
[TBL] [Abstract][Full Text] [Related]
12. Beta-carotene-Encapsulated Solid Lipid Nanoparticles (BC-SLNs) as Promising Vehicle for Cancer: an Investigative Assessment.
Jain A; Sharma G; Thakur K; Raza K; Shivhare US; Ghoshal G; Katare OP
AAPS PharmSciTech; 2019 Feb; 20(3):100. PubMed ID: 30721373
[TBL] [Abstract][Full Text] [Related]
13. Streptomycin sulphate loaded solid lipid nanoparticles show enhanced uptake in macrophage, lower MIC in Mycobacterium and improved oral bioavailability.
Singh M; Schiavone N; Papucci L; Maan P; Kaur J; Singh G; Nandi U; Nosi D; Tani A; Khuller GK; Priya M; Singh R; Kaur IP
Eur J Pharm Biopharm; 2021 Mar; 160():100-124. PubMed ID: 33497794
[TBL] [Abstract][Full Text] [Related]
14. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
15. Magnesium lithospermate B loaded PEGylated solid lipid nanoparticles for improved oral bioavailability.
Kang X; Chen H; Li S; Jie L; Hu J; Wang X; Qi J; Ying X; Du Y
Colloids Surf B Biointerfaces; 2018 Jan; 161():597-605. PubMed ID: 29156336
[TBL] [Abstract][Full Text] [Related]
16. Microencapsulated Solid Lipid Nanoparticles as a Hybrid Platform for Pulmonary Antibiotic Delivery.
Gaspar DP; Gaspar MM; Eleutério CV; Grenha A; Blanco M; Gonçalves LMD; Taboada P; Almeida AJ; Remuñán-López C
Mol Pharm; 2017 Sep; 14(9):2977-2990. PubMed ID: 28809501
[TBL] [Abstract][Full Text] [Related]
17. Solid lipid nanoparticles with enteric coating for improving stability, palatability, and oral bioavailability of enrofloxacin.
Li C; Zhou K; Chen D; Xu W; Tao Y; Pan Y; Meng K; Shabbir MAB; Liu Q; Huang L; Xie S
Int J Nanomedicine; 2019; 14():1619-1631. PubMed ID: 30880969
[TBL] [Abstract][Full Text] [Related]
18. Polyester-Solid Lipid Mixed Nanoparticles with Improved Stability in Gastro-Intestinal Tract Facilitated Oral Delivery of Larotaxel.
Gou J; Feng S; Liang Y; Fang G; Zhang H; Yin T; Zhang Y; He H; Wang Y; Tang X
Mol Pharm; 2017 Nov; 14(11):3750-3761. PubMed ID: 28945434
[TBL] [Abstract][Full Text] [Related]
19. Enhanced brain targeting efficacy of Olanzapine through solid lipid nanoparticles.
Natarajan J; Baskaran M; Humtsoe LC; Vadivelan R; Justin A
Artif Cells Nanomed Biotechnol; 2017 Mar; 45(2):364-371. PubMed ID: 27002542
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, tissue distribution and relative bioavailability of geniposide-solid lipid nanoparticles following oral administration.
Wang F; Cao J; Hao J; Liu K
J Microencapsul; 2014; 31(4):382-9. PubMed ID: 24697172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
